Sp868

CHALLENGES AND OPPORTUNITIES FOR MASLD DETECTION AND RISK STRATIFICATION

Date
May 20, 2024

Speaker

Speaker Image for W Ray Kim
Stanford University

Tracks

Related Products

Thumbnail for AASLD Presidential Plenary
AASLD Presidential Plenary
ASSOCIATION OF GLUCAGON-LIKE PEPTIDE-1 AGONISTS WITH CIRRHOSIS AND HEPATOCELLULAR CANCER IN METABOLIC DYSFUNCTION ASSOCIATED STEATOTIC LIVER DISEASE (MASLD)
Thumbnail for LONG-TERM OUTCOMES IN LIVER TRANSPLANT RECIPIENTS WITH DONOR-DERIVED HEPATITIS-C INFECTION
LONG-TERM OUTCOMES IN LIVER TRANSPLANT RECIPIENTS WITH DONOR-DERIVED HEPATITIS-C INFECTION
Transplantation of hepatitis C (HCV) positive lungs has been shown to be a safe means of combating organ shortages in the era of direct-acting antivirals against HCV…
Thumbnail for NOVEL MACHINE LEARNING APPROACHES TO THE NON-INVASIVE DIAGNOSIS OF LIVER FIBROSIS IN NAFLD
NOVEL MACHINE LEARNING APPROACHES TO THE NON-INVASIVE DIAGNOSIS OF LIVER FIBROSIS IN NAFLD
Background: Current non-invasive tests (NITs) utilized to screen and predict liver fibrosis were developed in predominantly Caucasian populations, and their performance in non-Caucasians is not well known…